SynthesisBMC oral health2026
Proteolytic enzymes in dentin erosion: roles of matrix metalloproteinases and cathepsins and the effectiveness of synthetic and natural inhibitors-a systematic review.
Synthesis in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the role of matrix metalloproteinases (MMPs) and cathepsins in dentin erosion and assess the efficacy of synthetic and natural inhibitors in preventing collagen matrix degradation and preserving dentin integrity.
methodsA systematic literature search was conducted and updated in January 2025 across PubMed, Scopus, and Web of Science, targeting studies that investigated the role of matrix metalloproteinases (MMPs) and/or cysteine cathepsins in dentin erosion or erosion-abrasion models. In vitro, in situ, and in vivo experimental studies evaluating the effects of synthetic and natural protease inhibitors were included. Study selection, data extraction, and risk of bias assessment were performed following PRISMA 2020 guidelines.
resultsA total of 22 studies met the inclusion criteria, comprising predominantly in vitro designs, alongside in situ and combined experimental models. Across studies, MMP-2, MMP-8, and MMP-9, together with cathepsin K, were consistently identified as key enzymes involved in collagen degradation following acidic challenges. Erosive protocols varied in pH, exposure time, and cycling frequency, but uniformly promoted demineralization and enzymatic activation. Synthetic inhibitors (e.g., ferrous sulfate, stannous fluoride) and natural compounds (e.g., green tea catechins, theaflavins) demonstrated significant reductions in enzymatic activity and dentin loss. Importantly, studies assessing combined inhibition of MMPs and cathepsins reported the greatest protective effects, supporting a multimodal strategy to limit erosive dentin degradation.
conclusionsAcidic challenges promote the activation of matrix metalloproteinases and cysteine cathepsins, thereby accelerating dentin erosion through progressive collagen degradation. Both synthetic and natural inhibitors were shown to attenuate proteolytic activity and reduce dentin loss under experimental conditions. Notably, strategies targeting multiple enzymatic pathways consistently demonstrated greater protective effects than single-agent approaches. Nevertheless, the predominance of in vitro and in situ evidence highlights the need for well-designed clinical studies to confirm the long-term efficacy and translational relevance of these interventions. CLINICAL SIGNIFICANCE: The incorporation of MMP and cathepsin inhibitors into preventive and therapeutic oral care strategies represents a promising adjunct for enhancing dentin resistance to erosive challenges. However, clinical implementation requires standardized experimental protocols, clearer dose-response characterization, and validation in long-term clinical settings. Advancing dual-targeted inhibitory approaches may contribute to more effective and durable dentin preservation in patients at risk of erosive tooth wear.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.